Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Authors' reply.

Hofstedt O, Di Giuseppe D, Alenius GM, Stattin N, Forsblad-D'Elia H, Ljung L.

Scand J Rheumatol. 2020 Mar;49(2):171-172. doi: 10.1080/03009742.2019.1701074. No abstract available.

PMID:
32207393
2.

Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register.

Hofstedt O, Di Giuseppe D, Alenius GM, Stattin N, Forsblad-D'Elia H, Ljung L.

Scand J Rheumatol. 2019 Jul;48(4):326-330. doi: 10.1080/03009742.2018.1551964. Epub 2019 Feb 13. Update in: Scand J Rheumatol. 2020 Mar;49(2):169-170. Scand J Rheumatol. 2020 Mar;49(2):171-172.

PMID:
30758242
3.

Mosquitoborne Sindbis Virus Infection and Long-Term Illness.

Gylfe Å, Ribers Å, Forsman O, Bucht G, Alenius GM, Wållberg-Jonsson S, Ahlm C, Evander M.

Emerg Infect Dis. 2018 Jun;24(6):1141-1142. doi: 10.3201/eid2406.170892.

4.

DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.

Lindqvist U, Wernroth ML, Husmark T, Larsson P, Geijer M, Teleman A, Theander E, Alenius GM.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):936-942. Epub 2017 Jun 16.

PMID:
28628468
5.

Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis.

Juneblad K, Rantapää-Dahlqvist S, Alenius GM.

J Rheumatol. 2016 Dec;43(12):2155-2161. Epub 2016 Oct 1.

PMID:
27909142
6.

The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis.

Geijer M, Lindqvist U, Husmark T, Alenius GM, Larsson PT, Teleman A, Theander E.

J Rheumatol. 2015 Nov;42(11):2110-7. doi: 10.3899/jrheum.150165. Epub 2015 Oct 15.

PMID:
26472410
7.

Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Jul 6;6:7741. doi: 10.1038/ncomms8741. No abstract available.

8.

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus.

Bowes J, Loehr S, Budu-Aggrey A, Uebe S, Bruce IN, Feletar M, Marzo-Ortega H, Helliwell P, Ryan AW, Kane D, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, Brown MA, Behrens F, Burkhardt H, McHugh N, Huffmeier U, Ho P, Reis A, Barton A.

Ann Rheum Dis. 2015 Oct;74(10):1882-5. doi: 10.1136/annrheumdis-2014-207187. Epub 2015 Apr 28.

9.

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Feb 5;6:6046. doi: 10.1038/ncomms7046. Erratum in: Nat Commun. 2015;6:7741.

10.

S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis.

Hansson C, Eriksson C, Alenius GM.

J Immunol Res. 2014;2014:696415. doi: 10.1155/2014/696415. Epub 2014 May 14.

11.

Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis.

Apel M, Uebe S, Bowes J, Giardina E, Korendowych E, Juneblad K, Pasutto F, Ekici AB, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Padyukov L, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A, Hüffmeier U.

Arthritis Rheum. 2013 May;65(5):1224-31. doi: 10.1002/art.37885.

12.

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).

Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist UR.

Ann Rheum Dis. 2014 Feb;73(2):407-13. doi: 10.1136/annrheumdis-2012-201972. Epub 2013 Jan 25.

PMID:
23355078
13.

Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis.

Juneblad K, Johansson M, Rantapää-Dahlqvist S, Alenius GM.

Arthritis Res Ther. 2011 Mar 16;13(2):R45. doi: 10.1186/ar3284.

14.

Diagnostic properties of metabolic perturbations in rheumatoid arthritis.

Madsen RK, Lundstedt T, Gabrielsson J, Sennbro CJ, Alenius GM, Moritz T, Rantapää-Dahlqvist S, Trygg J.

Arthritis Res Ther. 2011 Feb 8;13(1):R19. doi: 10.1186/ar3243.

15.

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

Hüffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Lascorz J, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Herold C, Steffens M, Klareskog L, Wienker TF, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A.

Nat Genet. 2010 Nov;42(11):996-9. doi: 10.1038/ng.688. Epub 2010 Oct 17.

16.

Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?

Alenius GM, Eriksson C, Rantapää Dahlqvist S.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1):120-3.

PMID:
19327240
17.

The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.

Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmström G, Larsson PT; Psoriatic Arthritis Group of the Society for Rheumatology.

J Rheumatol. 2008 Apr;35(4):668-73. Epub 2008 Feb 15.

PMID:
18278834
18.

Psoriatic arthritis-new insights give new options for treatment.

Alenius GM.

Curr Med Chem. 2007;14(3):359-66. Review.

PMID:
17305538
19.

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation.

Alenius GM, Berglin E, Rantapää Dahlqvist S.

Ann Rheum Dis. 2006 Mar;65(3):398-400. Epub 2005 Aug 11.

20.

Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis.

Alenius GM, Friberg C, Nilsson S, Wahlström J, Dahlqvist SR, Samuelsson L.

J Rheumatol. 2004 Nov;31(11):2230-5.

PMID:
15517637
22.

Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden.

Alenius GM, Jidell E, Nordmark L, Rantapää Dahlqvist S.

Clin Rheumatol. 2002 Sep;21(5):357-62.

PMID:
12223981
23.

Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.

Alenius GM, Jonsson S, Wållberg Jonsson S, Ny A, Rantapää Dahlqvist S.

Clin Exp Rheumatol. 2001 Nov-Dec;19(6):760. No abstract available.

PMID:
11791658
24.

Renal abnormalities in a population of patients with psoriatic arthritis.

Alenius GM, Stegmayr BG, Dahlqvist SR.

Scand J Rheumatol. 2001;30(5):271-4.

PMID:
11727841
25.

A multicase family with spondylarthropathies.

Alenius GM, Sojka BN, Nordmark L, Nordström S, Rantapää-Dahlqvist S.

Scand J Rheumatol. 1997;26(2):107-12.

PMID:
9137325
26.

[Can hard training and low caloric intake induce and force anorectic behavior?].

Stålnacke BM, Alenius GM.

Lakartidningen. 1992 Dec 9;89(50):4356-8. Swedish. No abstract available.

PMID:
1469970

Supplemental Content

Loading ...
Support Center